Literature DB >> 21652693

A crucial sequence for transglutaminase type 2 extracellular trafficking in renal tubular epithelial cells lies in its N-terminal beta-sandwich domain.

Che-Yi Chou1, Andrew J Streets, Philip F Watson, Linghong Huang, Elisabetta A M Verderio, Timothy S Johnson.   

Abstract

Transglutaminase type 2 (TG2) catalyzes the formation of an ε-(γ-glutamyl)-lysine isopeptide bond between adjacent peptides or proteins including those of the extracellular matrix (ECM). Elevated extracellular TG2 leads to accelerated ECM deposition and reduced clearance that underlie tissue scarring and fibrosis. The extracellular trafficking of TG2 is crucial to its role in ECM homeostasis; however, the mechanism by which TG2 escapes the cell is unknown as it has no signal leader peptide and therefore cannot be transported classically. Understanding TG2 transport may highlight novel mechanisms to interfere with the extracellular function of TG2 as isoform-specific TG2 inhibitors remain elusive. Mammalian expression vectors were constructed containing domain deletions of TG2. These were transfected into three kidney tubular epithelial cell lines, and TG2 export was assessed to identify critical domains. Point mutation was then used to highlight specific sequences within the domain required for TG2 export. The removal of β-sandwich domain prevented all TG2 export. Mutations of Asp(94) and Asp(97) within the N-terminal β-sandwich domain were identified as crucial for TG2 externalization. These form part of a previously identified fibronectin binding domain ((88)WTATVVDQQDCTLSLQLTT(106)). However, siRNA knockdown of fibronectin failed to affect TG2 export. The sequence (88)WTATVVDQQDCTLSLQLTT(106) within the β-sandwich domain of TG2 is critical to its export in tubular epithelial cell lines. The extracellular trafficking of TG2 is independent of fibronectin.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21652693      PMCID: PMC3149372          DOI: 10.1074/jbc.M111.226340

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Increases in renal epsilon-(gamma-glutamyl)-lysine crosslinks result from compartment-specific changes in tissue transglutaminase in early experimental diabetic nephropathy: pathologic implications.

Authors:  N J Skill; M Griffin; A M El Nahas; T Sanai; J L Haylor; M Fisher; M F Jamie; N N Mould; T S Johnson
Journal:  Lab Invest       Date:  2001-05       Impact factor: 5.662

2.  An improved colorimetric assay for the measurement of transglutaminase (type II) -(gamma-glutamyl) lysine cross-linking activity.

Authors:  Susan M Trigwell; Paul T Lynch; Martin Griffin; Alan J Hargreaves; Philip L R Bonner
Journal:  Anal Biochem       Date:  2004-07-01       Impact factor: 3.365

3.  Do changes in transglutaminase activity alter latent transforming growth factor beta activation in experimental diabetic nephropathy?

Authors:  Linghong Huang; John L Haylor; Marie Fisher; Zoe Hau; A Meguid El Nahas; Martin Griffin; Timothy S Johnson
Journal:  Nephrol Dial Transplant       Date:  2010-05-26       Impact factor: 5.992

4.  Thrombin upregulates tissue transglutaminase in endothelial cells: a potential role for tissue transglutaminase in stability of atherosclerotic plaque.

Authors:  G C Auld; H Ritchie; L A Robbie; N A Booth
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-10       Impact factor: 8.311

5.  Transglutaminase-mediated cross-linking is involved in the stabilization of extracellular matrix in human liver fibrosis.

Authors:  P Grenard; S Bresson-Hadni; S El Alaoui; M Chevallier; D A Vuitton; S Ricard-Blum
Journal:  J Hepatol       Date:  2001-09       Impact factor: 25.083

6.  Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin.

Authors:  S S Akimov; A M Belkin
Journal:  Blood       Date:  2001-09-01       Impact factor: 22.113

7.  Tissue transglutaminase and the progression of human renal scarring.

Authors:  Timothy S Johnson; Ahmed F El-Koraie; N James Skill; Nahed M Baddour; A Meguid El Nahas; Melvin Njloma; Ahmed G Adam; Martin Griffin
Journal:  J Am Soc Nephrol       Date:  2003-08       Impact factor: 10.121

8.  A novel transport pathway for a yeast plasma membrane protein encoded by a localized mRNA.

Authors:  Christoph Jüschke; Dunja Ferring; Ralf-Peter Jansen; Matthias Seedorf
Journal:  Curr Biol       Date:  2004-03-09       Impact factor: 10.834

Review 9.  P2Y and P2X purinoceptor mediated Ca2+ signalling in glial cell pathology in the central nervous system.

Authors:  Greg James; Arthur M Butt
Journal:  Eur J Pharmacol       Date:  2002-07-05       Impact factor: 4.432

10.  Cell-surface transglutaminase promotes fibronectin assembly via interaction with the gelatin-binding domain of fibronectin: a role in TGFbeta-dependent matrix deposition.

Authors:  S S Akimov; A M Belkin
Journal:  J Cell Sci       Date:  2001-08       Impact factor: 5.285

View more
  15 in total

Review 1.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

2.  Syndecan-4 knockout leads to reduced extracellular transglutaminase-2 and protects against tubulointerstitial fibrosis.

Authors:  Alessandra Scarpellini; Linghong Huang; Izhar Burhan; Nina Schroeder; Muriel Funck; Timothy S Johnson; Elisabetta A M Verderio
Journal:  J Am Soc Nephrol       Date:  2013-12-19       Impact factor: 10.121

3.  Characterization of heparin-binding site of tissue transglutaminase: its importance in cell surface targeting, matrix deposition, and cell signaling.

Authors:  Zhuo Wang; Russell J Collighan; Kamila Pytel; Daniel L Rathbone; Xiaoling Li; Martin Griffin
Journal:  J Biol Chem       Date:  2012-02-01       Impact factor: 5.157

4.  Proteomic Profiling Reveals the Transglutaminase-2 Externalization Pathway in Kidneys after Unilateral Ureteric Obstruction.

Authors:  Giulia Furini; Nina Schroeder; Linghong Huang; David Boocock; Alessandra Scarpellini; Clare Coveney; Elisa Tonoli; Raghavendran Ramaswamy; Graham Ball; Claudia Verderio; Timothy S Johnson; Elisabetta A M Verderio
Journal:  J Am Soc Nephrol       Date:  2018-01-30       Impact factor: 10.121

5.  Upregulation of transglutaminase and ε (γ-glutamyl)-lysine in the Fisher-Lewis rat model of chronic allograft nephropathy.

Authors:  Badri Shrestha; Imran Butt; Michelle Da Silva; Armando Sanchez-Lara; Bart Wagner; Andrew Raftery; Timothy Johnson; John Haylor
Journal:  Biomed Res Int       Date:  2014-07-21       Impact factor: 3.411

6.  Urinary myeloid IgA Fc alpha receptor (CD89) and transglutaminase-2 as new biomarkers for active IgA nephropathy and henoch-Schönlein purpura nephritis.

Authors:  Rafael N Moresco; Marijn M Speeckaert; Slawomir C Zmonarski; Magdalena Krajewska; Ewa Komuda-Leszek; Agnieszka Perkowska-Ptasinska; Loreto Gesualdo; Maria T Rocchetti; Sigurd E Delanghe; Raymond Vanholder; Wim Van Biesen; Joris R Delanghe
Journal:  BBA Clin       Date:  2016-02-17

7.  Tissue transglutaminase in astrocytes is enhanced by inflammatory mediators and is involved in the formation of fibronectin fibril-like structures.

Authors:  Nathaly Espitia Pinzón; John J P Brevé; John G J M Bol; Benjamin Drukarch; Wia Baron; Anne-Marie van Dam
Journal:  J Neuroinflammation       Date:  2017-12-28       Impact factor: 8.322

8.  Dermatan sulfate is a player in the transglutaminase 2 interaction network.

Authors:  Grzegorz Wisowski; Ewa M Koźma; Tomasz Bielecki; Adam Pudełko; Krystyna Olczyk
Journal:  PLoS One       Date:  2017-02-15       Impact factor: 3.240

9.  P2X7 receptor activation regulates rapid unconventional export of transglutaminase-2.

Authors:  Magdalena Adamczyk; Rhiannon Griffiths; Sharon Dewitt; Vera Knäuper; Daniel Aeschlimann
Journal:  J Cell Sci       Date:  2015-11-05       Impact factor: 5.285

10.  Interplay between transglutaminases and heparan sulphate in progressive renal scarring.

Authors:  Izhar Burhan; Giulia Furini; Hugues Lortat-Jacob; Adeola G Atobatele; Alessandra Scarpellini; Nina Schroeder; John Atkinson; Mabrouka Maamra; Faith H Nutter; Philip Watson; Manlio Vinciguerra; Timothy S Johnson; Elisabetta A M Verderio
Journal:  Sci Rep       Date:  2016-10-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.